Efficacy of Intravenous Dexamethasone on Postoperative Caudal Analgesia in Pediatric Orchiopexy

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01041378

Enrollment

Registered

2009-12-31

Start date

2010-01-31

Completion date

2010-05-31

Last updated

2010-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

Pediatric patients (6 months-5 years) scheduled elective day-case orchiopexy

Brief summary

The purpose of this study is to evaluate postoperative pain control for pediatric patients.

Interventions

DRUGdexamethasone

Intravenous dexamethasone (0.5mg/kg) before incision

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

ALL

Age

6 Months to 5 Years

Healthy volunteers

Inclusion criteria

* Pediatric patients scheduled for elective day-case orchiopexy.

Exclusion criteria

* Infants or children with history of steroid allergy, renal, hepatic disease, or contraindication for caudal analgesia.

Design outcomes

Primary

Measure	Time frame
Children's Hospital of Eastern Ontario Pain Scale, CHEOPS and Faces, Legs, Activity, Cry, and Consolability, FLACC	postoperative 24 hours

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 31, 2026